Yumanity Therapeutics's total assets for Q3 2022 were $9.58M, a decrease of -38.08% from the previous quarter. YMTX total liabilities were $4.10M for the fiscal quarter, a -45.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.